trans-sialidase from Trypanosoma cruzi induces apoptosis in cells from the immune system in vivo

Journal of Infectious Diseases

Volumn 180, Issue 4, 1999, Pages 1398-1402

  Leguizamón, M Susana ^a   Mocetti, Esteban ^b   Rivello, Hernan García ^b   Argibay, Pablo ^b   Campetella, Oscar ^c  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^c UNIVERSIDAD NACIONAL DE SAN MARTÍN   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

SIALIC ACID; SIALIDASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL MOTILITY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRYPANOSOMA CRUZI;

ANIMALS; ANTIGENS, PROTOZOAN; APOPTOSIS; CERCOPITHECUS AETHIOPS; FEMALE; GANGLIA; GLYCOPROTEINS; IMMUNE SYSTEM; IN SITU NICK-END LABELING; LYMPHOCYTES; MICE; MICE, INBRED BALB C; NEURAMINIDASE; PREGNANCY; RECOMBINANT PROTEINS; SPLEEN; T-LYMPHOCYTES; TRYPANOSOMA CRUZI; VERO CELLS;

EID: 0033394463     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315001     Document Type: Article

References (15)

1. Frasch AC. Trans-sialidase, SAPA amino acid repeats, and the relationship between Trypanosoma cruzi and the mammalian host. Parasitology 1994;108(Suppl):537-44.
2. de Titto EH, Araujo FG. Serum neuraminidase activity and hematological alterations in acute human Chagas' disease. Clin Immunol Immunopathol 1988;46:157-61.
3. Buscaglia CA, Campetella O, Leguizamon MS, Frasch ACC. The repetitive domain of Trypanosoma cruzi trans-sialidase enhances the immune response against the enzymatic domain. J Infect Dis 1998;177:431-6.
4. Leguizamón MS, Campetella O, González Cappa SM, Frasch ACC. Mice infected with Trypanosoma cruzi produce antibodies against the enzymatic domain of trans-sialidase that inhibit its activity. Infect Immun 1994;62:3441-6.
5. Buscaglia CA, Alfonso J, Campetella O, Frasch ACC. Tandem amino acid repeats from Trypanosoma cruzi shed antigens increase the half-life of proteins in blood. Blood 1999;93:2025-32.
6. Brener Z. The pathogenesis of Chagas' disease: an overview of current theories. In: Chagas' disease and the nervous system. Washington, DC: Pan American Health Organization 1994:32-52 (scientific publication 547).
7. DosReis GA, Fonseca MEF, Lopes MF. Programmed T-cell death in experimental Chagas' disease. Parasitol Today 1995;11:390-4.
8. Lopes MF, da Veiga VF, Santos AR, Fonseca MEF, DosReis G. Activation-induced CD4′ T cell death by apoptosis in experimental Chagas' disease. J Immunol 1995;154:744-52.
9. Martins GA, Cardoso MA, Aliberti JC, Silva JS. Nitric oxide induced apoptotic cell death in the acute phase of Trypanosoma cruzi infection in mice. Immunol Lett 1998;63:113-20.
10. Pillatte Y, Bignon J, Lambre CR. Sialic acids as important molecules in the regulation of the immune system: pathophysiological implications of sialidases in immunity. Glycobiology 1993;3:201-18.
11. Cremona ML, Campetella O, Sanchez DO, Frasch ACC. Enzymically inactive members of the trans-sialidase family from Trypanosoma cruzi display beta-galactose binding activity. Glycobiology 1999;9:581-7.
12. Kroemer G, Bosca L, Zamzami N, Marchetti P, Hortelano S, Martinez C. Detection of apoptosis and apoptosis-associated alterations. In: Lefkovits I, ed. Immunology methods manual. Vol 2. San Diego: Academic Press, 1997:1111-25.
13. Freire de Lima CG, Nunes MP, Corte Real S, et al. Proapoptotic activity of a Trypanosoma cruzi ceramide-containing glycolipid turned on in host macrophages by IFN-gamma. J Immunol 1998;161:4909-16.
14. Huang FP, Xu D, Esfandiari EO, Sands W, Wei XQ, Liew FY. Mice defective in Fas are highly susceptible to Leishmania major infection despite elevated IL-12 synthesis, strong Th1 responses, and enhanced nitric oxide production. J Immunol 1998;160:4143-7.
15. Nash PB, Purner MB, Leon RP, Clarke P, Duke RC, Curiel TJ. Toxoplasma gondii-infected cells are resistant to multiple inducers of apoptosis. J Immunol 1998;160:1824-30.